U.S. law makers seek answers on 'troubling' drug price increases

Reuters

1 March 2022 - Senators Elizabeth Warren and Amy Klobuchar and 11 other U.S. law makers pressed the president of the biggest pharmaceutical industry trade group Tuesday about what they said were "troubling price increases for brand name drugs" in January.

A letter to Stephen Ubl, president of the Pharmaceutical Research and Manufacturers of America (PhRMA), was signed by 12 Democrats as well as Senator Bernie Sanders, an independent. 

It asks PhRMA to explain the source of the price increases, and asks for information about research costs and revenue from the medicines.

Read Reuters article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing